Form 4: Marchex Director Granted 50,000 Stock Options

Marchex Inc. Director Donald Cogsville received a grant of 50,000 employee stock options for Class B Common Stock with an exercise price of $1.64, vesting over two years.

Summary

• Donald Cogsville, a Director of Marchex Inc. (MCHX), was granted 50,000 Employee Stock Options.
• The options have an exercise price of $1.64 per share.
• The transaction date for this grant was December 16, 2025.
• The options will vest in two equal tranches: 50% on December 16, 2026, and the remaining 50% on December 16, 2027, contingent on continued service on the Board.
• Full vesting of all options will occur upon a Change of Control, as defined in the option agreement.
• The expiration date for these options is December 16, 2035.
• Following this transaction, Donald Cogsville beneficially owns 50,000 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive step for aligning management and shareholder interests, though it is a routine compensation event and not indicative of a major operational or financial shift. It reflects standard corporate governance practices.

Positives

• The grant of stock options aligns the director's financial interests with the long-term performance and shareholder value of Marchex Inc.
• This is a standard component of director compensation, incentivizing continued service and strategic oversight.

Future Outlook

The options granted to Director Donald Cogsville are subject to a vesting schedule over the next two years, with the potential for full vesting upon a change of control. This provides a future incentive for the director's continued engagement and performance.

Industry Context

The grant of stock options to a director is a common practice across industries, serving as a key component of executive and director compensation packages. It is designed to incentivize long-term performance and align the interests of leadership with those of shareholders.

Comparison to Industry Standards

• This type of equity compensation, specifically stock option grants with multi-year vesting, is a standard practice for publicly traded companies to compensate and retain directors and executives.
• The vesting schedule (50% over two years) is typical for aligning long-term interests, similar to practices observed in technology and software companies of comparable size to Marchex Inc.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's incentives with shareholder value creation, potentially leading to more focused long-term strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The options will vest according to the specified schedule on December 16, 2026, and December 16, 2027.
• The director may exercise the vested options at any time before the expiration date of December 16, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of stock options to a director as part of their compensation. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The grant aligns the director's interests with shareholders, which is generally positive, but it's not a catalyst for a 'buy' or 'sell' decision.

Keywords

Marchex, MCHX, Stock Options, Director Compensation, Insider Transaction, Form 4, Equity Grant